Nutrien Ltd. $NTR Shares Sold by Clal Insurance Enterprises Holdings Ltd

Clal Insurance Enterprises Holdings Ltd reduced its position in shares of Nutrien Ltd. (NYSE:NTR) by 3.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,985,282 shares of the company’s stock after selling 100,000 shares during the period. Nutrien makes up approximately 1.3% of Clal Insurance Enterprises Holdings Ltd’s portfolio, making the stock its 19th largest position. Clal Insurance Enterprises Holdings Ltd owned about 0.62% of Nutrien worth $176,893,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in NTR. Norges Bank purchased a new stake in shares of Nutrien in the second quarter valued at approximately $395,842,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Nutrien by 48.5% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,944,730 shares of the company’s stock worth $696,058,000 after purchasing an additional 3,900,755 shares during the period. Boston Partners purchased a new position in shares of Nutrien in the 2nd quarter valued at about $150,416,000. First Eagle Investment Management LLC lifted its stake in shares of Nutrien by 14.0% in the second quarter. First Eagle Investment Management LLC now owns 13,268,229 shares of the company’s stock valued at $772,742,000 after purchasing an additional 1,627,328 shares during the period. Finally, TD Asset Management Inc increased its holdings in Nutrien by 16.5% in the third quarter. TD Asset Management Inc now owns 7,368,861 shares of the company’s stock valued at $432,838,000 after buying an additional 1,043,766 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Stock Up 2.7%

NTR opened at $75.07 on Friday. The company has a market cap of $36.12 billion, a PE ratio of 16.11 and a beta of 0.73. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.70 and a current ratio of 1.34. Nutrien Ltd. has a 1 year low of $45.78 and a 1 year high of $75.73. The firm has a 50 day moving average price of $67.31 and a 200 day moving average price of $61.21.

Nutrien (NYSE:NTR) last released its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Nutrien had a return on equity of 8.41% and a net margin of 8.43%.Nutrien’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.31 earnings per share. Sell-side analysts expect that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.9%. This is an increase from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date is Tuesday, March 31st. Nutrien’s payout ratio is 46.78%.

Analyst Ratings Changes

NTR has been the topic of several research analyst reports. Bank of America boosted their price target on Nutrien from $64.00 to $71.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Barclays raised their target price on shares of Nutrien from $64.00 to $70.00 and gave the company an “equal weight” rating in a report on Wednesday, February 18th. UBS Group boosted their price target on Nutrien from $58.00 to $63.00 and gave the stock a “neutral” rating in a report on Monday, January 12th. Zacks Research raised shares of Nutrien from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 27th. Finally, JPMorgan Chase & Co. lifted their price target on Nutrien from $68.00 to $78.00 and gave the company an “overweight” rating in a report on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $72.24.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.